References
- Cai B.C., Wang T.S., Kurokawa M., Shiraki K., Hattori M. (1998) Cytotoxicities of alkaloids from processed and unprocessed seeds of Strychnos nux-vomica, Zhongguo Yao Li Xue Bao 19, 425–428.
- Dewick PM (2002): Medicinal Natural Products; A Biosynthetic Approach, 2nd edn. Chichester, New York, John Wiley & Sons, pp. 81–82.
- Dobrzycka KM, Townson SM, Jiang S, Oesterreich S (2003):Estrogen receptor corepressors – a role in human breast cancer? Endocr Relat Cancer 10: 517–536.
- ElSohly MA Adawadkar PD, Ma CY, Turner CE (1982): Separation and characterization of poison ivy and poison oak urushiol components. J Nat Prod 45: 532–538.
- Farah I.O., Begum R.A. (1982): Effect of Nigella sativa (N.sativa L.) and oxidative stree on the survival pattern of MCF-7 breast cancer cells, Biomed Sci Instrum 39, 359–364.
- Fotsis T, Pepper MS, Aktas E, Breit S, Rasku S, Adlercreutz H, Wahala K, Montesano R, Schweigerer L (1997): Flavonoids, dietary-derived inhibitors of cell proliferation and in vitro angiogenesis. Cancer Res 57: 2916–2921.
- Goodman GE (1997): The clinical evaluation of cancer prevention agents. Proc Soc Exp Biol Med 216: 253–259.
- Hembree JA Chang CJ, McLaughlin JL, Peck G, Cassady JM (1978): The anticancer activity of Semecarpus anacardium. I. 9KB active pentadecylcatechols. Lloydia 41: 491–493.
- Indap MA, Gokhale SV (1983): Antitumor and pharmacological effects of the oil from Semecarpus anacardium Linn. Indian J Physiol Pharmacol 27: 83–91.
- Jemal A, Siegel R, Ward E, Murray T, Xu J, Smigal C, Thun MJ (2006): Cancer statistics, 2006. CA Cancer J Clin 56: 106–130.
- Lamture JB, Nayak UR, Patwardhan BK, Ghooi RB (1982): Semecarpus anacardium. Separation of the bhilawanols A and B and a comparative study of their growth inhibitory effect on Clostridium tetani and general pharmacology. Bulletin of Haffkin Institute 10: 87–92.
- Lee S.E., Ju E.M., Kim J.H. (2001): Free radical scavenging and antioxidant enzyme fortifying activities ffrom Smilax china root. Exp Mol Med 33, 263–268.
- Osborne CK (1998): Steroid hormone receptors in breast cancer management. Breast Cancer Res Treat 51: 227–238.
- Prakasa Rao NS, Ramachandra RL, Brown RT (1973): Phenolic constituents of Semecarpus anacardium. Phytochemistry 12: 671–681.
- Prasad V.S., Devi P.U., Rao B.S., Kamath R (1996): Radiosenitizing effect of plumbagin on mouse melanoma cells grown in vitro, Indian J Exp Biol 34, 857–858.
- Rochefort H, Glondu M, Sahla ME, Platet N, Garcia M (2003): How to target estrogen receptor-negative breast cancer? Endocr Relat Cancer 10: 261–266.
- Schally AV, Nagy A (1999): Cancer chemotherapy based on targeting of cytotoxic peptide conjugates to their receptors on tumors. Eur J Endocrinol 141: 1–14.
- Shin YG, Cordell GA, Dong Y, Pezzuto JM, Rao AVNA, Ramesh M, Kumar BR, Radakhishan, M (1999): Rapid identification of cytotoxic alkenyl catechols in Semecarpus anacardium using bioassay-linked high performance liquid chromatography-electrospray/mass spectrometric analysis. Phytochem Anal 10: 208–212.
- Singh DK, Lippman SM (1998): Cancer chemoprevention. Part 1: Retinoids and carotenoids and other classic antioxidants. Oncology (Williston Park) 12: 1643–1653, 1657–1648; discussion 1659–1660.
- Singh RP, Agarwal R (2002): Flavonoid antioxidant silymarin and skin cancer. Antioxid Redox Signal 4: 655–663.
- Sowmyalakshmi S, Nur EAM, Akbarsha MA, Thirugnanam S, Rohr J, Chendil D (2005): Investigation on Semecarpus Lehyam – a Siddha medicine for breast cancer. Planta 220: 910–918.
- Sujatha V., Sachdanandam P. (2002): Recuperative effect of Semecarpus anacardium linn. nut milk extract on carbohydrate metabolizing enzymes in experimental mammary carcinoma-bearing rats, Phytother Res 16 Suppl 1, 14–18.